Ruxolitinib Patient Selection in Polycythemia Vera
Targeted Oncology Patients who are continuing to require phlebotomy even though they're on hydroxyurea, now, that's been the standard of care for decades. As I said, when patients were randomized to best available therapy, what did the doctor do with their patient? They ... |
from phlebotomy - Google News http://bit.ly/2epX2jR
No comments:
Post a Comment